From Tik­Tok to the Os­cars: How mar­ket­ing obe­si­ty drugs is no longer just the purview of Eli Lil­ly and No­vo Nordisk

Obe­si­ty drugs have a brand­ing prob­lem.

Thanks to Tik­Tok, Hol­ly­wood gos­sip and ea­ger med­ical spas and clin­i­cians, few peo­ple both­er to dis­tin­guish the names and in­di­ca­tions of Eli Lil­ly and No­vo Nordisk’s block­buster GLP-1s.

“When I look around at this room I can’t help but won­der, ‘Is Ozem­pic right for me?’” Os­cars host Jim­my Kim­mel joked at last year’s cer­e­mo­ny, us­ing the brand name of No­vo’s type 2 di­a­betes treat­ment in ref­er­ence to weight loss.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER